Search Results - "Wallis, Erica"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    CARDIOVASCULAR AND CORONARY RISK ESTIMATION IN HYPERTENSION MANAGEMENT by Wallis, Erica J, Ramsay, Lawrence E, Jackson, Peter R

    Published in Heart (British Cardiac Society) (01-09-2002)
    “…Antihypertensive treatment decreases the risk of all cardiovascular complications by about 25%, largely through reducing stroke by 38% and coronary events by…”
    Get full text
    Journal Article
  2. 2

    Statins for primary prevention: at what coronary risk is safety assured? by Jackson, Peter R., Wallis, Erica J., Haq, Ifti U., Ramsay, Lawrence E.

    Published in British journal of clinical pharmacology (01-10-2001)
    “…Aims  Increasingly HMG CoA reductase inhibitors (statins) are being used for primary prevention of vascular disease in patients with a raised cholesterol but…”
    Get full text
    Journal Article
  3. 3

    Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods by Yikona, Joseph INM, Wallis, Erica J, Ramsay, Lawrence E, Jackson, Peter R

    Published in Journal of hypertension (01-11-2002)
    “…OBJECTIVE To compare the accuracy of five risk assessment methods in identifying patients with uncomplicated mild hypertension at high coronary heart disease…”
    Get full text
    Journal Article
  4. 4

    Coronary and cardiovascular risk estimation for primary prevention:validation of a new Sheffield table in the 1995 Scottish health survey population by Wallis, Erica J, Ramsay, Lawrence E, Haq, Iftikhar UI, Ghahramani, Parviz, Jackson, Peter R, Yeo, Karen Rowland, Yeo, Wilfred W

    Published in BMJ (11-03-2000)
    “…Abstract Objective: To examine the accuracy of a new version of the Sheffield table designed to aid decisions on lipids screening and detect thresholds for…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation by Wallis, Erica J, Ramsay, Lawrence E, Haq, Iftikhar U, Ghahramani, Parviz, Jackson, Peter R

    Published in Journal of hypertension (01-04-2001)
    “…OBJECTIVETo examine the relationship between coronary (CHD) and cardiovascular (CVD) risk in patients with uncomplicated mild hypertension and to determine the…”
    Get full text
    Journal Article
  7. 7

    Primary and Secondary Prevention of Coronary Heart Disease by Wallis, Erica J, Ramsay, Lawrence E

    Published in Medicine (Abingdon. 1995, UK ed.) (2002)
    “…This contribution discusses the use of statins (HMG-CoA reductase inhibitors), aspirin and antihypertensive drugs in secondary and primary prevention of…”
    Get full text
    Journal Article
  8. 8

    Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension by Wallis, Erica J., Ramsay, Lawrence E., Hettiarachchi, Jayasena

    Published in Clinical pharmacology and therapeutics (01-10-1998)
    “…Background The antihypertensive response to angiotensin‐converting enzyme (ACE) inhibitors may be attenuated by a compensatory decrease in atrial natriuretic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Rationale for Differing National Recommendations for the Treatment of Hypertension by Ramsay, Lawrence E., Wallis, Erica J., Yeo, Wilfred W., Jackson, Peter R.

    Published in American journal of hypertension (01-06-1998)
    “…This article examines the rationale for the differences in the guidelines for hypertension management of four national or international bodies: the Joint…”
    Get full text
    Journal Article
  11. 11

    Coronary and cardiovascular risk estimation for primary prevention : validation of a new Sheffield table in the 1995 Scottish health survey population by WALLIS, E. J, RAMSAY, L. E, HAQ, I. U, GHAHRAMANI, P, JACKSON, P. R, ROWLAND-YEO, K, YEO, W. W

    “…The results of a study to examine the accuracy of a new version of the Sheffield table designed to aid decisions on lipids screening and detect thresholds for…”
    Get full text
    Journal Article
  12. 12

    Implication of recent trials with b-hydroxy-b-methylglutaryl coenzyme A reductase inhibitors for hypertension management by HAQ, I. U, WALLIS, E. J, JACKSON, P. R, YEO, W. W, RAMSAY, L. E

    Published in Journal of hypertension (01-11-1999)
    “…There is broad agreement that statin treatment should be targeted at absolute coronary heart disease (CHD) risk but no consensus on the level of risk to…”
    Get full text
    Journal Article
  13. 13

    Aspirin for primary prevention by Ramsay, Lawrence E., Sanmuganathan, Philemon S., Wallis, Erica J., Jackson, Peter R., Alkhenizan, Abdullah

    Published in BMJ (09-12-2000)
    “…EDITOR-We have suggested that aspirin for primary prevention is safe and worthwhile when the estimated 10 year coronary risk is >15%, provided that any…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Comparison of methods of estimating coronary risk by Wallis, Erica J., Ramsay, Lawrence E., Yikona, Joseph I. N. M., Jackson, Peter R., Isles, Christopher, Ritchie, Lewis

    Published in BMJ (15-07-2000)
    “…Like the Sheffield table and New Zealand guideline it can be used as a screening tool: it gives clinicians an opportunity not to measure serum lipid…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18